Moderna, Inc.
MRNA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001682852
In the last 90 days, Moderna, Inc. insiders filed 0 open-market purchases and 5 sales; 784 institutions reported holding it in 13F filings for Q2 2026, worth $22.3B in total; no superinvestor holds it.
Holders of 5% or more of MRNA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Moderna, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 13G/A | 10.60%41.3M shares | +3.40 ppfrom 7.20% | May 12, 20254 filings | Feb 6, 2026 | SEC |
| Baillie Gifford & Co | 13G/A | 5.30%20.6M shares | −1.20 ppfrom 6.50% | Feb 12, 20253 filings | Feb 9, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on Moderna, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 30, 202611:30 AM ET | Vanguard Capital Management LLC | 13G | 6.53%25.9M shares | New | Mar 31, 2026 | SEC |
| Mar 27, 202610:51 AM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 9, 202610:48 AM ET | Baillie Gifford & Co | 13G/A | 5.30%20.6M shares | −1.20 ppfrom 6.50% | Dec 31, 2025 | SEC |
| Feb 6, 20261:10 PM ET | FMR LLCand 1 other | 13G/A | 10.60%41.3M shares | +3.40 ppfrom 7.20% | Jan 30, 2026 | SEC |
| Feb 5, 20261:31 PM ET | FMR LLCand 1 other | 13G | 7.20%28.0M shares | +4.00 ppfrom 3.20% | Dec 31, 2025 | SEC |
| Nov 5, 202511:40 AM ET | FMR LLCand 1 other | 13G/A | 3.20%12.3M shares | −2.30 ppfrom 5.50%Below 5% | Sep 30, 2025 | SEC |
| May 12, 202510:36 AM ET | FMR LLCand 1 other | 13G | 5.50%21.1M shares | New | Mar 31, 2025 | SEC |
| Apr 30, 20256:47 AM ET | Baillie Gifford & Co | 13G/A | 6.50%24.9M shares | −3.60 ppfrom 10.10% | Mar 31, 2025 | SEC |
| Feb 12, 20259:07 AM ET | Baillie Gifford & Co | 13G/A | 10.10%38.9M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Moderna, Inc. shares.
No Form 144 notices for Moderna, Inc. are on file.